投资者关系新闻2020-08-24SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&DPreview上一篇四环医药：轩竹(石家庄)生物科技引入重磅级股东下一篇Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry
